The profile of HIV-1 drug resistance in Shanghai, China: a retrospective study from 2017 to 2021
Min Zhang(Henan University of Science and Technology), Hongzhou Lu(Southern University of Science and Technology), Chiyu Zhang(Chinese Academy of Sciences), Jianping Qiu(Shanghai Public Health Clinical Center), Gang Wang(Fudan University), Xin Li(Shihezi University), Zhenyan Wang(Shanghai Public Health Clinical Center), Yingying Ma(Northeast Agricultural University), Feng Lin(Fudan University), Daihong Chen(Shanghai Public Health Clinical Center), Qianying Wang(Chinese Academy of Sciences), Yinzhong Shen(Fudan University)
Cited by 8
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|655
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China
|JAMA Internal Medicine|2020|240
Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models
|Cell Research|2020|120
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
|Frontiers of Medicine|2021|80